These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 16103979)
1. Clinical trial results of new therapies for HBV: implications for treatment guidelines. Gish RG Semin Liver Dis; 2005; 25 Suppl 1():29-39. PubMed ID: 16103979 [TBL] [Abstract][Full Text] [Related]
2. Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China. Yao G J Antimicrob Chemother; 2007 Aug; 60(2):201-5. PubMed ID: 17556353 [TBL] [Abstract][Full Text] [Related]
4. Management of chronic hepatitis B virus infection: a new era of disease control. Farrell GC; Teoh NC Intern Med J; 2006 Feb; 36(2):100-13. PubMed ID: 16472264 [TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis B virus infection - Dutch national guidelines. Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL; Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260 [TBL] [Abstract][Full Text] [Related]
6. Entecavir for the treatment of chronic hepatitis B virus infection. Matthews SJ Clin Ther; 2006 Feb; 28(2):184-203. PubMed ID: 16678641 [TBL] [Abstract][Full Text] [Related]
7. Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Xu XW; Chen YG Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):350-9. PubMed ID: 16911930 [TBL] [Abstract][Full Text] [Related]
8. Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients. Cheng PN; Chang TT Expert Rev Anti Infect Ther; 2008 Oct; 6(5):569-79. PubMed ID: 18847396 [TBL] [Abstract][Full Text] [Related]
9. Special considerations and treatment of patients with HBV-HIV coinfection. Dieterich DT Antivir Ther; 2007; 12 Suppl 3():H43-51. PubMed ID: 18284182 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response. Baldick CJ; Eggers BJ; Fang J; Levine SM; Pokornowski KA; Rose RE; Yu CF; Tenney DJ; Colonno RJ J Hepatol; 2008 Jun; 48(6):895-902. PubMed ID: 18362040 [TBL] [Abstract][Full Text] [Related]
11. Entecavir: a new treatment option for chronic hepatitis B. Zoulim F J Clin Virol; 2006 May; 36(1):8-12. PubMed ID: 16515882 [TBL] [Abstract][Full Text] [Related]
12. Update on viral hepatitis: 2008. Degertekin B; Lok AS Curr Opin Gastroenterol; 2009 May; 25(3):180-5. PubMed ID: 19387254 [TBL] [Abstract][Full Text] [Related]
13. Chronic hepatitis B: who to treat and which choice of treatment? Di Marco V; Craxì A Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242 [TBL] [Abstract][Full Text] [Related]
14. [Entecavir - options and obstacles of an effective treatment for chronic hepatitis B]. Cornberg M; Manns MP Dtsch Med Wochenschr; 2010 Jan; 135(1-2):32-7. PubMed ID: 20024882 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B treatment: Current best practices, avoiding resistance. Gish RG Cleve Clin J Med; 2009 May; 76 Suppl 3():S14-9. PubMed ID: 19465704 [TBL] [Abstract][Full Text] [Related]
16. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Lok AS; Zoulim F; Locarnini S; Bartholomeusz A; Ghany MG; Pawlotsky JM; Liaw YF; Mizokami M; Kuiken C; Hepatology; 2007 Jul; 46(1):254-65. PubMed ID: 17596850 [TBL] [Abstract][Full Text] [Related]
17. [German guidelines on diagnosis and therapy of hepatitis B]. Wedemeyer H; Cornberg M; Protzer U; Berg T; Dollinger MM Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1775-82. PubMed ID: 17713890 [TBL] [Abstract][Full Text] [Related]
18. Antiviral therapy for hepatitis B virus associated hepatic failure. Wang YM; Tang YZ Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):17-24. PubMed ID: 19208509 [TBL] [Abstract][Full Text] [Related]
19. [New advances in the treatment of chronic hepatitis B: position of entecavir]. Olaso V Rev Esp Quimioter; 2007 Sep; 20(3):259-60. PubMed ID: 18080023 [No Abstract] [Full Text] [Related]
20. [Therapy of chronic hepatitis B]. Buti M; Esteban R Acta Gastroenterol Latinoam; 2008 Dec; 38(4):291-7. PubMed ID: 19157385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]